XML 18 R8.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 8 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2025
Cash flows from operating activities:    
Net loss $ (57,943) $ (75,850)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 9,769 20,125
Net accretion of premiums and discounts on marketable securities (4,340)
Non-cash interest expense 1,468
Non-cash lease expense 65 319
Depreciation expense 11 55
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (1,980) (3,167)
Other non-current assets (43) (60)
Accounts payable 1,621 (1,254)
Accrued expenses and other current liabilities 1,650 5,038
Operating lease liability 6 (468)
Related party accounts payable and other current liabilities 6,357 (6,014)
Net cash used in operating activities (39,019) (65,616)
Cash flows from investing activities:    
Purchases of property and equipment (171) (146)
Purchases of marketable securities (419,972)
Proceeds from maturities of marketable securities 345,395
Net cash used in investing activities (171) (74,723)
Cash flows from financing activities:    
Proceeds from issuance of Pre-Merger Oruka Series A Preferred Stock, net of issuance costs paid 2,931
Proceeds from issuance of notes payable to related party, net of issuance costs paid 24,980
Proceeds from the Pre-Closing Financing, net 228,127
Proceeds from the PIPE Financings, net 189,087 169,908
Cash acquired in connection with the reverse recapitalization 4,940
Proceeds from issuance of common stock 109
Net cash provided by financing activities 450,065 170,017
Net increase in cash and cash equivalents 410,875 29,678
Cash and cash equivalents at beginning of period 61,575
Cash and cash equivalents at end of period 410,875 91,253
Supplemental disclosures of non-cash operating and financing activities:    
Operating lease liability arising from obtaining operating right-of-use asset 982 1,412
Assets acquired in connection with the reverse recapitalization 114
Other liabilities assumed in connection with the reverse recapitalization (54)
Pre-Closing Financing and reverse recapitalization issuance costs included in accounts payable 150
PIPE Financing issuance costs included in accounts payable 374
PIPE Financing issuance costs included in accrued expenses and other current liabilities 6 264
Non-cash accrued interest on convertible note converted to common stock 1,468
Non-cash exchange of Pre-Merger Oruka Series A Preferred Stock for Company Series B Convertible Preferred Stock $ 2,931